DFDA

Furosemide

Treatment for Rheumatic Heart Disease

Typical Dosage: 20-80mg daily (or BID)

Effectiveness
80%
Safety Score
70%
Clinical Trials
1
Participants
60K

Comparative Safety Scale(Higher is safer)

Cyanideâ˜ ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
20-80mg daily (or BID)
Time to Effect
30-60 minutes (oral)
Treatment Duration
long-term, as needed
Evidence Quality
HIGH
Number Needed to Treat (NNT)
2(Treat 2 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
75(Treat 75 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$15
Monitoring:$250
Side Effect Mgmt:$50
Total Annual:$315
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$2,000/QALY
QALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$350
Prescription Access Economics
Risk Assessment
Requires Monitoring
Yes
Needs lab work/checkups
Furosemide Outcomes

for Rheumatic Heart Disease

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+90%
Common Side Effects
Hypokalemia
+20%
Dehydration
+10%
Hypotension
+10%
Ototoxicity
+0.5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Furosemide in Rheumatic Heart Disease

Effect of Simvastatin on Cardiac Function

NCT01178710COMPLETEDNA
View Study
151 participants
INTERVENTIONAL
Guangzhou, China
Started: Sep 1, 2010